Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Aga

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Gastroenterology|January 29, 2017
Rituximab-induced Crohn's diseasePoornima Varma, Julianne Falconer, Ahmad Aga, et al.
Current Oncology (Toronto, Ont.)|February 22, 2021
Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?Timothy Phan, Kurvi Patwala, Lara Lipton, et al.
BJR Case Reports|November 6, 2023
A rare case of MRI of myxoid hepatocellular adenoma with gadoxetic acid uptakeTze Wei Wilson Yang, Naveen Mayavel, Jan Frank Gerstenmaier, et al.
Virchows Archiv : an International Journal of Pathology|November 12, 2022
ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literatureLaurence A Galea, Michael S Hildebrand, Tom Witkowski, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Gastroenterology|January 29, 2017
Rituximab-induced Crohn's diseasePoornima Varma, Julianne Falconer, Ahmad Aga, et al.
Current Oncology (Toronto, Ont.)|February 22, 2021
Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?Timothy Phan, Kurvi Patwala, Lara Lipton, et al.
BJR Case Reports|November 6, 2023
A rare case of MRI of myxoid hepatocellular adenoma with gadoxetic acid uptakeTze Wei Wilson Yang, Naveen Mayavel, Jan Frank Gerstenmaier, et al.
Virchows Archiv : an International Journal of Pathology|November 12, 2022
ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literatureLaurence A Galea, Michael S Hildebrand, Tom Witkowski, et al.
Pageof 1